New Zealand markets open in 8 hours 11 minutes

ApicHope Pharmaceutical Co., Ltd (300723.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
20.10-1.18 (-5.55%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 9.66B
Enterprise value 10.23B
Trailing P/E 53.64
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.88
Price/book (mrq)3.68
Enterprise value/revenue 4.25
Enterprise value/EBITDA 38.07

Trading information

Stock price history

Beta (5Y monthly) 0.45
52-week change 3-24.83%
S&P500 52-week change 326.24%
52-week high 333.50
52-week low 317.50
50-day moving average 322.36
200-day moving average 324.91

Share statistics

Avg vol (3-month) 33.77M
Avg vol (10-day) 32.45M
Shares outstanding 5454.14M
Implied shares outstanding 6454.14M
Float 8164.12M
% held by insiders 169.01%
% held by institutions 111.28%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.21
Forward annual dividend yield 40.99%
Trailing annual dividend rate 30.21
Trailing annual dividend yield 30.99%
5-year average dividend yield 40.57
Payout ratio 450.42%
Dividend date 3N/A
Ex-dividend date 403 Jun 2024
Last split factor 21.5:1
Last split date 324 May 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 7.22%
Operating margin (ttm)19.28%

Management effectiveness

Return on assets (ttm)2.96%
Return on equity (ttm)5.76%

Income statement

Revenue (ttm)2.41B
Revenue per share (ttm)5.48
Quarterly revenue growth (yoy)-13.00%
Gross profit (ttm)N/A
EBITDA 388.75M
Net income avi to common (ttm)174.02M
Diluted EPS (ttm)0.40
Quarterly earnings growth (yoy)-9.50%

Balance sheet

Total cash (mrq)605.41M
Total cash per share (mrq)1.35
Total debt (mrq)1.18B
Total debt/equity (mrq)43.64%
Current ratio (mrq)1.05
Book value per share (mrq)5.84

Cash flow statement

Operating cash flow (ttm)479.87M
Levered free cash flow (ttm)3.82M